• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Impact of metabolism-disrupting chemicals and folic acid supplementation on liver injury and steatosis in mother-child pairs.代谢干扰化学物质和叶酸补充对母婴配对中肝损伤和脂肪变性的影响。
J Hepatol. 2025 Jun;82(6):956-966. doi: 10.1016/j.jhep.2024.11.050. Epub 2024 Dec 12.
2
Metabolism-Disrupting Chemical Mixtures during Pregnancy, Folic Acid Supplementation, and Liver Injury in Mother-Child Pairs.孕期代谢干扰化学混合物、叶酸补充与母婴对肝脏损伤
medRxiv. 2024 Jun 14:2024.06.13.24308903. doi: 10.1101/2024.06.13.24308903.
3
Multiple-micronutrient supplementation for women during pregnancy.孕期女性的多种微量营养素补充
Cochrane Database Syst Rev. 2017 Apr 13;4(4):CD004905. doi: 10.1002/14651858.CD004905.pub5.
4
Multiple-micronutrient supplementation for women during pregnancy.孕期妇女补充多种微量营养素
Cochrane Database Syst Rev. 2015 Nov 1;2015(11):CD004905. doi: 10.1002/14651858.CD004905.pub4.
5
Intermittent oral iron supplementation during pregnancy.孕期间歇性口服铁剂补充
Cochrane Database Syst Rev. 2015 Oct 19;2015(10):CD009997. doi: 10.1002/14651858.CD009997.pub2.
6
Silymarin for adults with metabolic dysfunction-associated steatotic liver disease.水飞蓟素用于患有代谢功能障碍相关脂肪性肝病的成年人。
Cochrane Database Syst Rev. 2025 Jun 24;6(6):CD015524. doi: 10.1002/14651858.CD015524.pub2.
7
Folate supplementation in people with sickle cell disease.镰状细胞病患者的叶酸补充
Cochrane Database Syst Rev. 2018 Mar 16;3(3):CD011130. doi: 10.1002/14651858.CD011130.pub3.
8
Folic acid with or without vitamin B12 for cognition and dementia.叶酸联合或不联合维生素B12对认知及痴呆的影响
Cochrane Database Syst Rev. 2003(4):CD004514. doi: 10.1002/14651858.CD004514.
9
Intermittent oral iron supplementation during pregnancy.孕期间歇性口服铁补充剂。
Cochrane Database Syst Rev. 2012 Jul 11;7(7):CD009997. doi: 10.1002/14651858.CD009997.
10
Folate supplementation in people with sickle cell disease.镰状细胞病患者的叶酸补充
Cochrane Database Syst Rev. 2016 Feb 16;2:CD011130. doi: 10.1002/14651858.CD011130.pub2.

引用本文的文献

1
Windows of susceptibility to air pollution during and surrounding pregnancy in relation to longitudinal maternal measures of adiposity and lipid profiles.孕期及围孕期空气污染易感性窗口与母亲肥胖及血脂纵向指标的关系。
Environ Res. 2025 Jun 1;274:121198. doi: 10.1016/j.envres.2025.121198. Epub 2025 Feb 20.

本文引用的文献

1
Association between endocrine-disrupting chemical mixtures and non-alcoholic fatty liver disease with metabolic syndrome as a mediator among adults: A population-based study in Korea.内分泌干扰化学混合物与非酒精性脂肪性肝病的关联:以代谢综合征为中介的成年人的基于人群的研究。韩国。
Ecotoxicol Environ Saf. 2024 May;276:116310. doi: 10.1016/j.ecoenv.2024.116310. Epub 2024 Apr 12.
2
Longitudinal associations between early-life fluoride exposures and cardiometabolic outcomes in school-aged children.儿童期氟暴露与成年后患心血管代谢疾病风险的相关性研究
Environ Int. 2024 Jan;183:108375. doi: 10.1016/j.envint.2023.108375. Epub 2023 Dec 13.
3
Short-term exposure to PM and 1.5 million deaths: a time-stratified case-crossover analysis in the Mexico City Metropolitan Area.短期暴露于 PM 和 150 万人死亡:墨西哥城大都市区的时间分层病例交叉分析。
Environ Health. 2023 Oct 17;22(1):70. doi: 10.1186/s12940-023-01024-4.
4
Serum folate associated with nonalcoholic fatty liver disease and advanced hepatic fibrosis.血清叶酸与非酒精性脂肪性肝病和肝纤维化进展相关。
Sci Rep. 2023 Aug 9;13(1):12933. doi: 10.1038/s41598-023-39641-1.
5
AGA Clinical Practice Update on the Role of Noninvasive Biomarkers in the Evaluation and Management of Nonalcoholic Fatty Liver Disease: Expert Review.AGA 临床实践更新:非侵入性生物标志物在非酒精性脂肪性肝病评估和管理中的作用:专家综述。
Gastroenterology. 2023 Oct;165(4):1080-1088. doi: 10.1053/j.gastro.2023.06.013. Epub 2023 Aug 4.
6
Effects of Folic Acid Supplementation on Liver Enzymes, Lipid Profile, and Insulin Resistance in Patients with Non-Alcoholic Fatty Liver Disease: A Randomized Controlled Trial.补充叶酸对非酒精性脂肪性肝病患者肝酶、血脂和胰岛素抵抗的影响:一项随机对照试验
Adv Biomed Res. 2023 Apr 27;12:103. doi: 10.4103/abr.abr_90_22. eCollection 2023.
7
Effects of the dicyclohexyl phthalate and di--hexyl phthalate administration on the oxidative stress-induced histopathological changes in the rat liver tissue correlated with serum biochemistry and hematological parameters.邻苯二甲酸二环己酯和邻苯二甲酸二己酯给药对氧化应激诱导的大鼠肝组织病理变化的影响与血清生化和血液学参数相关。
Front Endocrinol (Lausanne). 2023 May 19;14:1128202. doi: 10.3389/fendo.2023.1128202. eCollection 2023.
8
Predicting fine-scale daily NO over Mexico City using an ensemble modeling approach.使用集成建模方法预测墨西哥城的每日细粒度一氧化氮浓度。
Atmos Pollut Res. 2023 Jun;14(6). doi: 10.1016/j.apr.2023.101763. Epub 2023 Apr 17.
9
Prevalence, Risk Profiles, and National Implications of Nonalcoholic Fatty Liver Disease in Pregnant Individuals.孕妇非酒精性脂肪性肝病的患病率、风险概况及对国家的影响
Clin Gastroenterol Hepatol. 2024 Jan;22(1):194-196.e1. doi: 10.1016/j.cgh.2023.03.031. Epub 2023 Apr 7.
10
The association between endocrine disrupting chemicals and MAFLD: Evidence from NHANES survey.内分泌干扰化学物质与 MAFLD 的关联:来自 NHANES 调查的证据。
Ecotoxicol Environ Saf. 2023 May;256:114836. doi: 10.1016/j.ecoenv.2023.114836. Epub 2023 Mar 29.

代谢干扰化学物质和叶酸补充对母婴配对中肝损伤和脂肪变性的影响。

Impact of metabolism-disrupting chemicals and folic acid supplementation on liver injury and steatosis in mother-child pairs.

作者信息

India-Aldana Sandra, Midya Vishal, Betanzos-Robledo Larissa, Yao Meizhen, Alcalá Cecilia, Andra Syam S, Arora Manish, Calafat Antonia M, Chu Jaime, Deierlein Andrea, Estrada-Gutierrez Guadalupe, Jagani Ravikumar, Just Allan C, Kloog Itai, Landero Julio, Oulhote Youssef, Walker Ryan W, Yelamanchili Shirisha, Baccarelli Andrea A, Wright Robert O, Téllez Rojo Martha María, Colicino Elena, Cantoral Alejandra, Valvi Damaskini

机构信息

Department of Environmental Medicine and Climate Science, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Center for Nutrition and Health Research, National Institute of Public Health, Cuernavaca, Morelos, Mexico.

出版信息

J Hepatol. 2025 Jun;82(6):956-966. doi: 10.1016/j.jhep.2024.11.050. Epub 2024 Dec 12.

DOI:10.1016/j.jhep.2024.11.050
PMID:39674324
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12086056/
Abstract

BACKGROUND & AIMS: Scarce knowledge about the impact of metabolism-disrupting chemicals (MDCs) on steatotic liver disease limits opportunities for intervention. We evaluated pregnancy MDC-mixture associations with liver outcomes, and effect modification by folic acid (FA) supplementation in mother-child pairs.

METHODS

We studied ∼200 mother-child pairs from the Mexican PROGRESS cohort, with 43 MDCs measured during pregnancy (estimated air pollutants, blood/urine metals or metalloids, urine high- and low-molecular-weight phthalate [HMWPs, LMWPs] and organophosphate-pesticide metabolites), and serum liver enzymes (ALT, AST) at ∼9 years post-parturition. Outcomes included elevated liver enzymes in children and established clinical scores for steatosis and fibrosis in mothers (i.e.

, AST: ALT, FLI, HSI, FIB-4). Bayesian-weighted quantile sum regression assessed MDC-mixture associations with liver outcomes. We further examined chemical-chemical interactions and effect modification by self-reported FA supplementation.

RESULTS

In children, many MDC-mixtures were associated with liver injury. Per quartile HMWP-mixture increase, ALT increased by 10.1% (95% CI 1.67%, 19.4%) and AST by 5.27% (95% CI 0.80%, 10.1%). LMWP-mixtures and air pollutant-mixtures were associated with higher AST and ALT, respectively. Air pollutant and non-essential metal/element associations with liver enzymes were attenuated by maternal cobalt blood concentrations (p-interactions <0.05). In mothers, only the LMWP-mixture was associated with odds for steatosis (odds ratio = 1.53, 95% CI 1.01-2.28 for HSI >36, and odds ratio 1.62, 95% CI 1.05-2.49 for AST:ALT <1). In mothers and children, most associations were attenuated (null) at FA supplementation ≥600 μg/day (p-interactions <0.05).

CONCLUSIONS

Pregnancy MDC exposures may increase risk of liver injury and steatosis, particularly in children. Adequate FA supplementation and maternal cobalt levels may attenuate these associations.

IMPACT AND IMPLICATIONS

The effects of environmental chemical exposures on steatotic liver diseases are not well understood. In a parallel investigation of mothers and children, we found that pregnancy exposures to metabolism-disrupting chemicals may increase the risk of liver injury and steatosis, especially in the child, and that these associations could be attenuated by higher folic acid and/or cobalt levels. These findings can inform policies to decrease environmental chemical pollution and contribute to the design of clinical interventions addressing the metabolic dysfunction-associated steatotic liver disease epidemic.

摘要

背景与目的

关于代谢干扰化学物质(MDCs)对脂肪性肝病影响的知识匮乏,限制了干预机会。我们评估了母婴对中孕期MDC混合物与肝脏结局的关联,以及叶酸(FA)补充剂的效应修正作用。

方法

我们研究了来自墨西哥PROGRESS队列的约200对母婴,测量了孕期的43种MDCs(估计的空气污染物、血液/尿液中的金属或类金属、尿液中的高和低分子量邻苯二甲酸盐[HMWPs、LMWPs]以及有机磷农药代谢物),并在产后约9年测量了血清肝酶(ALT、AST)。结局包括儿童肝酶升高以及母亲脂肪变性和纤维化的既定临床评分(即AST:ALT、FLI、HSI、FIB-4)。贝叶斯加权分位数和回归评估了MDC混合物与肝脏结局的关联。我们进一步研究了化学物质之间的相互作用以及自我报告的FA补充剂的效应修正作用。

结果

在儿童中,许多MDC混合物与肝损伤有关。HMWP混合物每增加一个四分位数,ALT升高10.1%(95%CI 1.67%,19.4%),AST升高5.27%(95%CI 0.80%,10.1%)。LMWP混合物和空气污染物混合物分别与较高的AST和ALT有关。空气污染物以及非必需金属/元素与肝酶的关联因母亲血液中的钴浓度而减弱(p相互作用<0.05)。在母亲中,只有LMWP混合物与脂肪变性的几率有关(对于HSI>36,比值比=1.53,95%CI 1.01-2.28;对于AST:ALT<1,比值比1.62,95%CI 1.05-2.49)。在母亲和儿童中,当FA补充剂≥600μg/天时,大多数关联减弱(无关联)(p相互作用<0.05)。

结论

孕期接触MDCs可能增加肝损伤和脂肪变性的风险,尤其是在儿童中。充足的FA补充剂和母亲的钴水平可能减弱这些关联。

影响与意义

环境化学物质暴露对脂肪性肝病的影响尚不清楚。在一项对母亲和儿童的平行调查中,我们发现孕期接触代谢干扰化学物质可能增加肝损伤和脂肪变性的风险,尤其是在儿童中,并且这些关联可能因较高的叶酸和/或钴水平而减弱。这些发现可为减少环境化学污染的政策提供依据,并有助于设计针对与代谢功能障碍相关的脂肪性肝病流行的临床干预措施。